News/ News/ R&D Boehringer takes alteplase to phase 3 for COVID, but drops antibody Phil Taylor alteplase, antibody, Boehringer Ingelheim, coronavirus, COVID-19, thrombolysis 0 Comment Boehringer Ingelheim’s latecomer antibody therapy for COVID-19 has been side-lined, as the company focuses its attention on its Share X Boehringer takes alteplase to phase 3 for COVID, but drops antibody https://pharmaphorum.com/news/boehringer-takes-alteplase-to-phase-3-for-covid-but-drops-antibody/